Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?
Egan
L J
LJ
Sandborn
W J
WJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002460:Cell Line; D003106:Colon / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D012460:Sulfasalazine / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005765:Gastrointestinal Agents; D016328:NF-kappa B; D012460:Sulfasalazine